Sign up to save your podcasts
Or
Share S5 E4: Interview with Prof Miriam Santer on BMJ Spironolactone for acne in GP; physician associates; once-weekly insulin; tirzepatide vs insulin for T2DM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S5 E4: Interview with Prof Miriam Santer on BMJ Spironolactone for acne in GP; physician associates; once-weekly insulin; tirzepatide vs insulin for T2DM
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. The highlight of this episode is our interview with Prof Miriam Santer, lead author of recent research in the BMJ exploring the effectiveness of spironolactone for acne in women.
Does it work? Is it a treatment for general practice? And if so, is it safe, what monitoring is required, and where does it fit with current acne pathways?
In the news, we think about the current issues around physician associates in general practice. In research we have two papers on diabetes: first, in the Lancet, is a new once-weekly insulin injection as effective as a daily treatment for type 1 diabetes; and second, in JAMA, is the additional tirzepatide better than prandial insulin in addition to glargine for managing type 2 diabetes?
References
Eczema Care Online
BMJ Spiro for acne
Lancet Once weekly insulin vs daily insulin in T1DM
JAMA Tirzepatide vs prandial insulin in T2DM
www.nbmedical.com/podcast
View all episodes
By NB Medical Education
5
33 ratings
Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. The highlight of this episode is our interview with Prof Miriam Santer, lead author of recent research in the BMJ exploring the effectiveness of spironolactone for acne in women.
Does it work? Is it a treatment for general practice? And if so, is it safe, what monitoring is required, and where does it fit with current acne pathways?
In the news, we think about the current issues around physician associates in general practice. In research we have two papers on diabetes: first, in the Lancet, is a new once-weekly insulin injection as effective as a daily treatment for type 1 diabetes; and second, in JAMA, is the additional tirzepatide better than prandial insulin in addition to glargine for managing type 2 diabetes?
References
Eczema Care Online
BMJ Spiro for acne
Lancet Once weekly insulin vs daily insulin in T1DM
JAMA Tirzepatide vs prandial insulin in T2DM
www.nbmedical.com/podcast
More shows like NB Hot Topics Podcast
View all
Inside Health
101 Listeners
Medicine and Science from The BMJ
42 Listeners
The Good GP
13 Listeners
BMJ Best Practice Podcast
23 Listeners
Feel Better, Live More with Dr Rangan Chatterjee
3,479 Listeners
Primary Care Knowledge Boost
43 Listeners
You Are Not A Frog
8 Listeners
RCGP eLearning Podcast
5 Listeners
GPnotebook Podcast
21 Listeners
Talking General Practice
0 Listeners
Medics Money podcast
5 Listeners
ZOE Science & Nutrition
2,057 Listeners
The Rest Is Politics
3,100 Listeners
The Rest Is Politics: Leading
872 Listeners
Red Whale Primary Care Pod
5 Listeners